SiteOne Therapeutics
SiteOne Therapeutics is developing novel small molecule therapeutics targeting sodium channels for pain and neurological disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $100M
About
SiteOne Therapeutics is developing novel small molecule therapeutics targeting sodium channels for pain and neurological disorders.
NeuroscienceSmall Molecules
Funding History
1Total raised:$100M
PIPE$100M